Human CCR7 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB197R
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Neutralization
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Mouse IgG2A Clone # 150503R
Product Specifications
Immunogen
Human CCR7 transfectants
Met1-Pro378
Accession # AAA58615
Met1-Pro378
Accession # AAA58615
Specificity
Detects human CCR7.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Scientific Data Images for Human CCR7 Antibody
Detection of CCR7 in Human PBMCs by Flow Cytomtetry.
Human peripheral blood mononuclear cells (PBMCs) were stained with PE-conjugated Mouse anti-Human CD4 Monoclonal Antibody (Catalog # FAB3791P) and either (A) Mouse anti-Human CCR7 Monoclonal Antibody (Catalog # MAB197R) or (B) Mouse IgG2Aisotype control antibody (Catalog # MAB003) followed by APC-conjugated anti-mouse IgG secondary antibody (Catalog # F0101B). View our protocol for Staining Membrane-associated Proteins.Chemotaxis Induced by CCL19/MIP-3 beta and Neutral-ization by Human CCR7 Antibody.
Recombinant Human CCL19/MIP-3 beta (Catalog # 361-MI) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR7 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Human CCL19/MIP-3 beta (50 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human CCR7 Monoclonal Antibody (Catalog # MAB197R). The ND50 is typically 1-5 µg/mL.Applications for Human CCR7 Antibody
Application
Recommended Usage
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
Flow Cytometry
0.25 µg/106 cells
Sample: Human peripheral blood mononuclear cells (PBMCs)
Sample: Human peripheral blood mononuclear cells (PBMCs)
Neutralization
Measured by its ability to neutralize CCL19/MIP‑3 beta-induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CCR7. The Neutralization Dose (ND50) is typically 1-5 µg/mL in the presence of 50 ng/mL Recombinant Human CCL19/MIP‑3 beta.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCR7
Alternate Names
BLR2, CC-CKR-7, CCR7, CD197, CDw197, CMKBR7, EBI1
Gene Symbol
CCR7
UniProt
Additional CCR7 Products
Product Documents for Human CCR7 Antibody
Product Specific Notices for Human CCR7 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...